Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Gelfanova

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Society for Mass Spectrometry|May 22, 2014
A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencingChloe N Poston, Richard E Higgs, Jinsam You, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanismLingzhi Zhao, Suizhen Lin, Kelly R Bales, et al.
Science (New York, N.Y.)|November 15, 2003
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting RhoYan Zhou, Yuan Su, Baolin Li, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Mabs|May 18, 2019
Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity riskNicoletta Bivi, Terry Moore, George Rodgers, et al.
Briefings in Functional Genomics & Proteomics|June 23, 2007
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometryValentina Gelfanova, Richard E Higgs, Robert A Dean, et al.
Journal of Proteome Research|January 25, 2007
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical modelSandeep T Patil, Richard E Higgs, John E Brandt, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Society for Mass Spectrometry|May 22, 2014
A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencingChloe N Poston, Richard E Higgs, Jinsam You, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanismLingzhi Zhao, Suizhen Lin, Kelly R Bales, et al.
Science (New York, N.Y.)|November 15, 2003
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting RhoYan Zhou, Yuan Su, Baolin Li, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Mabs|May 18, 2019
Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity riskNicoletta Bivi, Terry Moore, George Rodgers, et al.
Briefings in Functional Genomics & Proteomics|June 23, 2007
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometryValentina Gelfanova, Richard E Higgs, Robert A Dean, et al.
Journal of Proteome Research|January 25, 2007
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical modelSandeep T Patil, Richard E Higgs, John E Brandt, et al.
Pageof 2